ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.687,44
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08349
-0,18%
Bitcoin
70.075,40
-0,08%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Omeros Corporation (OMER)

  7. Omeros Corporation (OMER) News

OMER

Omeros (OMER)

Omeros Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OMER
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202422h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
15/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
15/05/202422h02Business WireOmeros Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:OMEROmeros Corporation
10/05/202414h50Business WireOmeros Corporation to Announce First Quarter Financial Results on May 15, 2024NASDAQ:OMEROmeros Corporation
09/05/202414h50Business WireOmeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:OMEROmeros Corporation
01/04/202422h02Business WireOmeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
27/03/202413h30Business WireOmeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024NASDAQ:OMEROmeros Corporation
20/02/202415h00Business WireOmeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
14/02/202412h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMEROmeros Corporation
07/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
01/02/202415h11Business WireOmeros Corporation Announces Additional Royalty Monetization with DRI Healthcare TrustNASDAQ:OMEROmeros Corporation
29/01/202421h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OMEROmeros Corporation
22/11/202302h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202303h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202303h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202303h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
16/11/202303h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
09/11/202322h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
09/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
09/11/202322h02Business WireOmeros Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
06/11/202314h00Business WireOmeros Corporation to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:OMEROmeros Corporation
03/11/202314h05Business WireOmeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
02/11/202314h05Business WireOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingNASDAQ:OMEROmeros Corporation
19/10/202314h30Business WireOmeros Corporation Hires Andreas Grauer M.D. as Chief Medical OfficerNASDAQ:OMEROmeros Corporation
16/10/202322h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
16/10/202313h30Business WireOmeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA NephropathyNASDAQ:OMEROmeros Corporation
27/09/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
27/09/202322h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
27/09/202322h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
20/09/202322h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OMEROmeros Corporation
 Showing the most relevant articles for your search:NASDAQ:OMER

Kürzlich von Ihnen besucht

LSE
GOA
EU
BEAR00547487
Aspa
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten